Community pharmacists' contribution to public health: Assessing the global evidence base

Clinical Pharmacist

Volumn 10, Issue 4, 2018, Pages

  Agomo, Chijioke ^a   Udoh, Arit ^a   Kpokiri, Eneyi ^a   Osuku Opio, John ^a  

^a NONE

Author keywords

Alcohol dependence; Community pharmacy; Emergency hormonal contraception; Health promotion; Prevention; Public health; Smoking cessation; Vaccination; Weight management

Indexed keywords

CONTRACEPTIVE AGENT;

ARTICLE; BODY WEIGHT MANAGEMENT; COMMUNITY PHARMACIST; HEALTH PROMOTION; HORMONAL CONTRACEPTION; HUMAN; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH; SCREENING; SEXUAL HEALTH; SMOKING CESSATION; VACCINATION;

EID: 85054930576     PISSN: 17589061     EISSN: None     Source Type: Journal    
DOI: 10.1211/CP.2018.20204556     Document Type: Article

References (103)

1. World Health Organization. Constitution of WHO: principles. 2014. Available at: http://www.who.int/about/mission/en(accessed April 2018)
2. Dahlgren G & Whitehead M. Policies and strategies to promote social equity in health. 1991. Available at: https://core.ac.uk/download/pdf/6472456.pdf (accessed April 2018)
3. Hunter DJ, Marks L & Smith K. The public health system in England: a scoping study. 2007. Available at: https://core.ac.uk/download/pdf/28964369.pdf (accessed April 2018)
4. Faculty of Public Health. What is public health? 2006. Available at: http://www.fph.org.uk/what_is_public_health(accessed April 2018)
5. World Health Organization Regional Office of Europe. Public Health Services. 2015. Available at: http://www.euro.who.int/en/health-topics/Health-systems/public-health-services/public-health-services (accessed April 2018)
6. Walker R. Pharmaceutical public health: the end of pharmaceutical care? Pharm J 2000;264:340–341.
7. Braddick L, Bryson S, Crawford F et al. Pharmacy for Health: the Way Forward for Pharmaceutical Public Health in Scotland. 2002. Available at: http://www.healthscotland.com/uploads/documents/1728-pharmacy.pdf (accessed April 2018)
8. Department of Health. Healthy Lives, Healthy People: Our Strategy for Public Health in England. 2010. Available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/216096/dh_127424.pdf (accessed April 2018)
9. Department of Health. Pharmacy in England: Building on Strengths — Delivering the Future 2008. Available at: http://www.official-documents.gov.uk/document/cm73/7341/7341.pd (accessed April 2018)
10. Public Health England. Consolidating and developing the evidence base and research for community pharmacy’s contribution to public health: a progress report from Task Group 3 of the Pharmacy and Public Health Forum. 2014. Available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/271682/20140110Community_pharmacy_contribution_to_public_health.pdf(accessed April 2018)
11. Pharmaceutical Services Negotiating Committee, National Pharmaceutical Association, Royal Pharmaceutical Societ of Great Britain & Pharmacy Health Link. Public Health: a Practical Guide for Community Pharmacists. 2004. Available at: http://docplayer.net/15771152-Public-health-a-practical-guide-for-community-pharmacists.html (accessed April 2018)
12. Department of Health. Choosing health through pharmacy: a programme for pharmaceutical public health 2005–2015. 2005. Available at: http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4107496.pdf (accessed April 2018)
13. National Center for Chronic Disease Prevention and Health Promotion. A Program Guide for Public Health: Partnering with the Pharmacist in the Prevention and Control of Chronic Diseases. 2012. Available at: https://www.cdc.gov/dhdsp/programs/spha/docs/pharmacist_guide.pdf (accessed April 2018)
14. World Health Organization. The role of pharmacists in the healthcare system: preparing the future pharmacist. 1997. http://apps.who.int/medicinedocs/pdf/s2214e/s2214e.pdf(accessed April 2018)
15. Todd A, Copeland A, Husband A et al. Access all areas? An area-level analysis of accessibility to general practice and community pharmacy services in England by urbanity and social deprivation. BMJ Open 2015;5:e007328. doi: 10.1136/bmjopen-2014-007328
16. Todd A, Copeland A, Husband A et al. The positive pharmacy care law: an area-level analysis of the relationship between community pharmacy distribution, urbanity and social deprivation in England. BMJ Open 2014;4:e005764. doi: 10.1136/bmjopen-2014-005764
17. Addo-Atuah J. Making a case for a public health orientation in global pharmacy education and practice in the context of the Millennium Development Goals (MDGs). Curr Pharm Teach Learn 2014;6(5):723–729. 10.1016/j.cptl.2014.05.019
18. Brown TJ, Todd A, O’Malley C et al. Community pharmacy-delivered interventions for public health priorities: a systematic review of interventions for alcohol reduction, smoking cessation and weight management, including meta-analysis for smoking cessation. BMJ Open 2016;6:e009828. doi: 10.1136/bmjopen-2015-009828
19. Saba M, Diep J, Saini B et al. Meta-analysis of the effectiveness of smoking cessation interventions in community pharmacy. J Clin Pharm Ther 2014;39(3):240–247. doi: 10.1111/jcpt.12131
20. Burson RC, Buttenheim AM, Armstrong A et al. Community pharmacies as sites of adult vaccination: a systematic review. Hum Vaccines Immunother 2016;12(12):3146–3159. doi: 10.1080/21645515.2016.1215393
21. Hermansyah A, Sainsbury E & Krass I. Community pharmacy and emerging public health initiatives in developing Southeast Asian countries: a systematic review. Health Soc Care Community 2016;24(5):e11–e22. doi: 10.1111/hsc.12289
22. Becker L & Oxman AD. Overviews of reviews. In: Higgins JP & Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.02. Oxford: The Cochrane Collaboration; 2009.
23. Biondi-Zoccai G. Umbrella Reviews: Evidence Synthesis with Overviews of Reviews and Meta-Epidemiologic Studies. Switzerland: Springer International Publishing; 2016.
24. National Institute for Health and Care Excellence. Methods for the development of NICE public health guidance. Process and methods (PMG4). 2012. Available at: https://www.nice.org.uk/process/pmg4/chapter/introduction(accessed April 2018)
25. Smith V, Devane D, Begley CM et al. Methodology in conducting a systematic review of systematic reviews of healthcare interventions. BMC Med Res Methodol 2011;11:15. doi: 10.1186/1471-2288-11-15
26. Agomo CO. The role of community pharmacists in public health: a scoping review of the literature. J Pharm Health Serv Res 2012;3(1):25–33. doi: 10.1111/j.1759-8893.2011.00074.x
27. Anderson C, Blenkinsopp A & Armstrong M. The contribution of community pharmacy to improving the public’s health REPORT 1 Evidence from the peer-reviewed literature 1990–2001. 2003. Available at: http://eprints.nottingham.ac.uk/1571/1/The_contribution_of_community_pharmacy_to_improving_the_public%27s_health_evidence_base_report_1.pdf (accessed April 2018)
28. El Hajj MS, Al Nakeeb RR & Al-Qudah RA. Smoking cessation counseling in Qatar: community pharmacists’ attitudes, role perceptions and practices. Int J Clin Pharm2012;34(4):667–676. doi: 10.1007/s11096-012-9663-x
29. William D, Newsom J & Brock T. An evaluation of smoking cessation-related activities by pharmacists. J Am Pharm Assoc2000;40(3):366–370. doi: 10.1016/S1086-5802(16)31084-1
30. Nimpitakpong P, Chaiyakunapruk N & Dhippayom T. A national survey of training and smoking cessation services provided in community pharmacies in Thailand. J Community Health 2010;35(5):554–559. doi: 10.1007/s10900-010-9242-9
31. Thananithisak C, Nimpitakpong P & Chaiyakunapruk N. Activities and perceptions of pharmacists providing tobacco control services in community pharmacy in Thailand. Nicotine Tob Res 2008;10(5):921–925. doi: 10.1080/14622200802027115
32. Çalgan Z, Tahir E, Yeǧenoǧlu S et al. Community pharmacists’ attitude, habits and actual activities regarding smoking and health promotion in the 1. Region of Ankara chamber of pharmacists. Turk J Pharm Sci 2007;4(3):125-138. Available at: http://cms.galenos.com.tr/Uploads/Article_12541/125-139.pdf(accessed April 2018)
33. Mohamed SS, Mahmoud AA & Ali AA. Involvement of Sudanese community pharmacists in public health activities. Int J Clin Pharm 2013;35(3):393–400. doi: 10.1007/s11096-012-9745-9
34. Hoch MA, Hudmon KS, Lee L et al. Pharmacists’ perceptions of participation in a community pharmacy-based nicotine replacement therapy distribution program. J Community Health2012;37(4):848–854. doi: 10.1007/s10900-011-9519-7
35. Kurko T, Linden K, Pietilä K et al. Community pharmacists’ involvement in smoking cessation: familiarity and implementation of the national smoking cessation guideline in Finland. BMC Public Health 2010;10:444. doi: 10.1186/1471-2458-10-444
36. Boardman HF & Avery AJ. Effectiveness of a community pharmacy weight management programme. Int J Clin Pharm2014;36(4):800–806. doi: 10.1007/s11096-014-9964-3
37. Um IS, Armour C, Krass I et al. Weight management in community pharmacy: what do the experts think? Int J Clin Pharm 2013;35(3): 447–454. doi: 10.1007/s11096-013-9761-4
38. Newlands RS, Watson MC & Lee AJ. The provision of current and future healthy weight management (HWM) services from community pharmacies: a survey of community pharmacists’ attitudes, practice and future possibilities. Int J Pharm Pract2011;19(2):106–114. doi: 10.1111/j.2042-7174.2010.00080.x
39. Weidmann AE, MacLure K, Marshall S et al. Promoting weight management services in community pharmacy: perspectives of the pharmacy team in Scotland. Int J Clin Pharm2015;37(4):599–606. doi: 10.1007/s11096-015-0102-7
40. Weidmann AE, Cunningham S, Gray G et al. Views of the Scottish general public on community pharmacy weight management services: international implications. Int J Clin Pharm 2012;34(2):389–397. doi: 10.1007/s11096-012-9624-4
41. Um IS, Armour C, Krass I et al. Consumer perspectives about weight management services in a community pharmacy setting in NSW, Australia. Health Expect 2014;17: 579–592. doi: 10.1111/j.1369-7625.2012.00788.x
42. Murphy BL & DiPietro NA. Impact of a pharmacist-directed educational program on the long-term knowledge and use of folic acid among college women: a 12-month follow-up study. Pharm Pract 2012;10(2):105–109. PMID: 24155825.
43. Mizoguchi M, Kuwano S, Suzuki I et al. Usefulness of oral care-related information provision at drugstores to prevent pneumonia. Yakugaku Zasshi 2016;136(12):1657-1666. doi: 10.1248/yakushi.16-00056
44. Castillo-García ML, Martínez-Raga J, López-Castellano AC et al. Health education in the community pharmacy: controlled study in the province of Castellon [Educación sanitaria en la farmacia comunitaria: estudio controlado en la provincia de Castellón.]. ARS Pharm 2011;52(4):5–11. Available at: http://revistaseug.ugr.es/index.php/ars/article/view/4756(accessed April 2018)
45. Beshir SA & Bt Hamzah NH. Health promotion and health education: perception, barriers and standard of practices of community pharmacists. Int J Health Promot Educ2014;52(4):174–180. doi: 10.1080/14635240.2014.888809
46. Ayoub NM, Nuseir KQ, Othman AK et al. Knowledge, attitudes and barriers towards breast cancer health education among community pharmacists. J Pharm Health Serv Res2016;7(3):189–198. doi: 10.1111/jphs.12140
47. Real JP, Gracia Vásquez SL, Formica ML et al. Challenges and opportunities related to health promotion in community pharmacies: obstacles and professional perspectives. Pharm Policy Law 2014;16(3–4):313–320. doi: 10.3233/PPL-140391
48. Laliberté M-C, Perreault S, Damestoy N et al. Ideal and actual involvement of community pharmacists in health promotion and prevention: a cross-sectional study in Quebec, Canada. BMC Public Health 2012;12(1). doi: 10.1186/1471-2458-12-192
49. Schmiedel K, Schlager H & Dörje F. Preventive counselling for public health in pharmacies in South Germany. Int J Clin Pharm 2013;35(1):138–144. doi: 10.1007/s11096-012-9722-3
50. Sandhu RK, Dolovich L, Deif B et al. High prevalence of modifiable stroke risk factors identified in a pharmacy-based screening programme. Open Heart 2016;3(2). doi: 10.1136/openhrt-2016-000515
51. Krass I, Mitchell B, Clarke P et al. Pharmacy diabetes care program: analysis of two screening methods for undiagnosed type 2 diabetes in Australian community pharmacy. Diabetes Res Clin Pract 2007;75:339–347. doi: 10.1016/j.diabres.2006.06.022
52. Schmiedel K, Friedland K & Schlager H. Evaluation of the Activities of Community Pharmacies during the annual campaign with focus on diabetes prevention [Evaluation der Aktivitäten öffentlicher Apotheken im Rahmen der Jahresschwerpunktkampagne „Diabetes bewegt uns!“]. Gesundheitswesen 2016;78(10):678–680. doi: 10.1055/s-0035-1564216
53. Sushilkumar PL, Mahendrakumar BJ, Suman B et al. Implementation and evaluation of health screening services to diabetic and hypertensive patients in a selected community pharmacy at Belgaum city. Asian J Pharm Clin Res2015;8(3):305–315. Available at: https://innovareacademics.in/journals/index.php/ajpcr/article/view/5758 (accessed April 2018)
54. Fuller JM, Wong KK, Krass I et al. Sleep disorders screening, sleep health awareness, and patient follow-up by community pharmacists in Australia. Patient Educ Couns 2011;83(3):325–335. doi: 10.1016/j.pec.2011.05.004
55. Perraudin C, Fleury B & Pelletier-Fleury N. Effectiveness of intervention led by a community pharmacist for improving recognition of sleep apnea in primary care — a cohort study. J Sleep Res 2015;24(2):167–173. doi: 10.1111/jsr.12230
56. Peterson GM, Jackson SL, Hughes JD et al. Public perceptions of the role of Australian pharmacists in cardiovascular disease. J Clin Pharm Ther 2010;35(6):671–677. doi: 10.1111/j.1365-2710.2009.01139.x
57. Tsuyuki RT, Al Hamarneh YN, Jones CA et al. The Effectiveness of pharmacist interventions on cardiovascular risk: the multicenter randomized controlled RxEACH trial. J Am Coll Cardiol 2016;67(24):2846–2854. doi: 0.1016/j.jacc.2016.03.528
58. Hourihan F, Krass I & Chen T. Rural community pharmacy: a feasible site for a health promotion and screening service for cardiovascular risk factors. Aust J Rural Health 2003;11(1):28–35. Available at: https://onlinelibrary.wiley.com/doi/abs/10.1046/j.1440-1584.2003.00468.x (accessed April 2018)
59. Krass I, Hourihan F & Chen T. Health promotion and screening for cardiovascular risk factors in NSW: a community pharmacy model. Health Promot J Aust 2003;14:101–107. doi: 10.1071/HE03101
60. Weidle PJ, Lecher S, Botts LW et al. HIV testing in community pharmacies and retail clinics: a model to expand access to screening for HIV infection. J Am Pharm Assoc2014;54(5):486–492. doi: 10.1331/JAPhA.2014.14045
61. Perraudin C, Fleury B & Pelletier-Fleury N. Effectiveness of intervention led by a community pharmacist for improving recognition of sleep apnea in primary care - A cohort study. J Sleep Res 2015;24(2):167-173. doi: 10.1111/jsr.12230
62. Lowres N, Krass I, Neubeck L et al. Atrial fibrillation screening in pharmacies using an iPhone ECG: a qualitative review of implementation. Int J Clin Pharm 2015;37:1111–1120. doi: 10.1007/s11096-015-0169-1
63. Watson L, Bond C & Gault C. A survey of community pharmacists on prevention of HIV and hepatitis B and C: current practice and attitudes in Grampian. J Public Health Med2003;25(1):13–18. doi: 10.1093/pubmed/fdg004
64. Isenor JE, Killen JL, Billard BA et al. Impact of pharmacists as immunizers on influenza vaccination coverage in the community-setting in Nova Scotia, Canada: 2013–2015. J Pharm Policy Pract 2016;9(1):32. doi: 10.1186/s40545-016-0084-4
65. Buchan SA, Rosella LC, Finkelstein M et al. Impact of pharmacist administration of influenza vaccines on uptake in Canada. CMAJ 2017;189(4):E146–E152. doi: 10.1503/cmaj.151027
66. Kulczycki A, Wensel TM & Hogue M. Practices, challenges, and opportunities to improving pneumococcal immunization in working-age, at-risk adults through community pharmacies. Infect Dis Clin Pract 2017;25(1):23–28. doi: 10.1097/IPC.0000000000000452
67. Evans AM, Wood FC & Carter B. National community pharmacy NHS influenza vaccination service in Wales: a primary care mixed methods study. Br J Gen Pract 2016;66(645):e248–e257. doi: 10.3399/bjgp16X684349
68. Valiquette JR & Bédard P. Community pharmacists’ knowledge, beliefs and attitudes towards immunization in Quebec. Can J Public Health 2015;106(3):e89–e94. doi: 10.17269/CJPH.106.4880
69. Watson MC & Blenkinsopp A. The feasibility of providing community pharmacy-based services for alcohol misuse: a literature review. Int J Pharm Pract 2009;17(4):199-205. doi: 10.1211/ijpp.17.04.0002
70. Khan NS, Norman IJ, Dhital R et al. Alcohol brief intervention in community pharmacies: a feasibility study of outcomes and customer experiences. Int J Clin Pharm2013;35(6):1178–1187. doi: 10.1007/s11096-013-9845-1
71. McCaig D, Fitzgerald N & Stewart D. Provision of advice on alcohol use in community pharmacy: a cross-sectional survey of pharmacists’ practice, knowledge, views and confidence. Int J Pharm Pract 2011;19(3):171–178. doi: 10.1111/j.2042-7174.2011.00111.x
72. Sheridan J, Stewart J, Smart R et al. Risky drinking among community pharmacy customers in New Zealand and their attitudes towards pharmacist screening and brief interventions. Drug Alcohol Rev 2012;31(1):56–63. doi: 10.1111/j.1465-3362.2011.00293.x
73. Horsfield E, Sheridan J & Anderson C. What do community pharmacists think about undertaking screening and brief interventions with problem drinkers? Results of a qualitative study in New Zealand and England. Int J Pharm Pract2011;19(3):192–200. doi: 10.1111/j.2042-7174.2011.00112.x
74. Cochran G, Bacci JL, Ylioja T et al. Prescription opioid use: patient characteristics and misuse in community pharmacy. J Am Pharm Assoc 2016;56(3):248–256.e6. doi: 10.1016/j.japh.2016.02.012
75. Anderson C & Blenkinsopp A. Community pharmacy supply of emergency hormonal contraception: a structured literature review of international evidence. Hum Reprod Oxf Engl2006;21(1):272–284. doi: 10.1093/humrep/dei287
76. Baraitser P, Pearce V, Holmes J et al. Chlamydia testing in community pharmacies: evaluation of a feasibility pilot in south east London. Qual Saf Health Care 2007;16(4):303–307. doi: 10.1136/qshc.2006.020883
77. Gale A & Watson MC. The provision of current and future sexual health services from community pharmacies in Grampian, Scotland. Int J Clin Pharm 2011;33(2):183–190. doi: 10.1007/s11096-010-9458-x
78. Oswald K & Adcock H. Community pharmacy care delivered at no net cost to public purse in 2015. Pharm J 2016;297(7893) online. doi: 10.1211/PJ.2016.20201678
79. Watson MC, Holland R, Ferguson J et al. Community Pharmacy Management of Minor Illness: the MINA Study. Final report to Pharmacy Research UK. 2014. Available at: https://pharmacyresearchuk.org/wpcontent/uploads/2014/01/MINA-Study-Final-Report.pdf(accessed April 2018)
80. Royal Pharmaceutical Society. Shaping pharmacy for the future — improving urgent and emergency care through better use of pharmacists. 2014. Available at: https://www.rpharms.com/Portals/0/RPS%20document%20library/Open%20access/Policy%20statements/urgent-andemergency-care.pdf (accessed April 2018)
81. Wright D, Twigg M & Thornley T. Chronic obstructive pulmonary disease case finding by community pharmacists: a potential cost-effective public health intervention. Int J Pharm Pract 2015;23(1):83–85. doi: 10.1111/ijpp.12161
82. Wright D, Twigg M, Barton G et al. An evaluation of a multi-site community pharmacy-based chronic obstructive pulmonary disease support service. Int J Pharm Pract 2015;23(1):36–43. doi: 10.1111/ijpp.12165
83. Thavorn K & Chaiyakunapruk N. A cost-effectiveness analysis of a community pharmacist-based smoking cessation programme in Thailand. Tob Control 2008;17(3):177–182. doi: 10.1136/tc.2007.022368
84. Perraudin C, Le Vaillant M & Pelletier-Fleury N. Cost-effectiveness of a community pharmacist-led sleep apnea screening program — a Markov model. PLoS ONE2013;8(6):e63894. doi: 10.1371/journal.pone.0063894
85. Lowres N, Freedman SB, Redfern J et al. Screening education and recognition in community pharmacies of atrial fibrillation to prevent stroke in an ambulant population aged ≥65 years (SEARCH-AF stroke prevention study): a cross-sectional study protocol. BMJ Open 2012;2(3). doi: 10.1136/bmjopen-2012-001355
86. Agomo CO, Ogunleye J & Portlock J. A survey to identify barriers in the public health role of community pharmacists. J Pharm Health Serv Res 2016;7(4):253–261. doi: 10.1111/jphs.12153
87. Agomo CO & Ogunleye J. An investigation of strategies enhancing the public health role of community pharmacists: a review of knowledge and information. J Pharm Health Serv Res2014;5(2):135–145. doi: 10.1111/jphs.12056
88. Bush J, Langley CA & Wilson KA. The corporatization of community pharmacy: implications for service provision, the public health function, and pharmacy’s claims to professional status in the United Kingdom. Res Soc Adm Pharm 2009;5(4):305–318. doi: 10.1016/j.sapharm.2009.01.003
89. Saramunee K, Krska J, Mackridge A et al. How to enhance public health service utilization in community pharmacy? General public and health providers’ perspectives. Res Soc Adm Pharm 2014;10(2):272–284. doi: 10.1016/j.sapharm.2012.05.006
90. Agomo CO. Why UK pharmacy must adapt to the increasing demands of professionalism in practice. Int J Pharm Pract2012;20(5):320–323. doi: 10.1111/j.2042-7174.2012.00200.x
91. Agomo CO. Why improving the work–life balance of pharmacists might benefit employers and the profession. J Pharm Health Serv Res 2012;3(3):179–181. doi: 10.1111/j.1759-8893.2012.00096.x
92. The Scottish Government. Prescription for Excellence: a Vision and Action Plan for the Right Pharmaceutical Care through Integrated Partnerships and Innovation. 2013. Available at: http://www.gov.scot/resource/0043/00434053.pdf(accessed April 2018).
93. Agomo C. Why partnerships may be a magic wand. 2012. Pharm J 2012;288. Available at: http://www.pharmaceuticaljournal.com/opinion/comment/why-partnerships-may-be-a-magic-wand/11092342.article (accessed April 2018)
94. Agomo C, Ogunleye J & Portlock J. A survey to identify strategies to enhance the public health role of community pharmacists. Available at: https://researchportal.port.ac.uk/portal/files/4980801/A_survey_to_identity_barriers.pdf (accessed April 2018)
95. Agomo CO, Ogunleye J & Portlock J. Strategies enhancing the public health role of community pharmacists: a qualitative study. J Pharm Health Serv Res 2016;7(2):97–104. doi: 10.1111/jphs.12131
96. International Pharmaceutical Federation. Transforming our workforce. 2016. Available at: https://www.fip.org/files/fip/PharmacyEducation/2016_report/FIPEd_Transform_2016_online_version.pdf (accessed April 2018)
97. International Pharmaceutical Federation. Pharmaceutical Workforce Development Goals. 2016. Available at: https://fip.org/files/fip/PharmacyEducation/2016_report/2016-11-Education-workforce-developmentgoals.pdf (accessed April 2018)
98. International Pharmaceutical Federation. 2012 FIP Global Pharmacy Workforce Report. 2012. Available at: https://www.fip.org/files/members/library/FIP_workforce_Report_2012.pdf (accessed April 2018)
99. DiPietro Mager NA & Farris KB. The Importance of Public Health in Pharmacy Education and Practice. Am J Pharm Educ2016;80(2). doi: 10.5688/ajpe80218
100. Agomo C. Strategies enhancing the public health role of community pharmacists in the UK [DProf thesis]. Hendon, London: Middlesex University, UK; 2017
101. International Pharmaceutical Federation. Quality Assurance of Pharmacy Education: the FIP Global Framework. 2014. Available at: http://www.fip.org/files/fip/PharmacyEducation/Quality_Assurance/QA_Framework_2nd_Edition_online_version.pdf (acce April 2018)
102. Pharmaceutical Services Negotiating Committee. PSNC briefing 052/16: flu vaccination: the benefits of a community pharmacy service 2016. Available at: http://psnc.org.uk/wp-content/uploads/2013/04/PSNC-Briefing-052.16-Fluvaccination-The-benefits-of-a-community-pharmacy-service.pdf (accessed April 2018)
103. Truong H & Patterson BY. Professional and educational initiatives, supports, and opportunities for advanced training in public health. Am J Pharm Educ 2010;74(7):122. doi: 10.5688/aj7407122